Alyeska Investment Group, L.P. Ab Cellera Biologics Inc. Transaction History

Alyeska Investment Group, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$9.48 - $14.52 $948,000 - $1.45 Million	100,000 New	100,000 $1.01 Million
Q2 2022 Aug 15, 2022	SELL	$5.72 - $10.65 $5.64 Million - $10.5 Million	-985,160 Reduced 56.89%	746,652 $7.95 Million
Q1 2022 May 16, 2022	BUY	$7.46 - $14.14 $2.35 Million - $4.45 Million	314,449 Added 22.19%	1,731,812 $16.9 Million
Q4 2021 Feb 14, 2022	BUY	$12.99 - $17.73 $17.5 Million - $23.9 Million	1,345,543 Added 1873.49%	1,417,363 $20.3 Million
Q3 2021 Nov 15, 2021	SELL	$14.85 - $21.34 $2.27 Million - $3.27 Million	-153,180 Reduced 68.08%	71,820 $1.44 Million
Q2 2021 Aug 16, 2021	BUY	$20.19 - $34.17 $504,750 - $854,250	25,000 Added 12.5%	225,000 $4.95 Million
Q1 2021 May 17, 2021	SELL	$23.29 - $53.2 $1.16 Million - $2.66 Million	-50,000 Reduced 20.0%	200,000 $6.79 Million
Q4 2020 Feb 16, 2021	BUY	$39.0 - $58.9 $9.75 Million - $14.7 Million	250,000 New	250,000 $10.1 Million

154

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $841M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.